Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

Congenital adrenal hyperplasia (CAH) was the fourth disorder added to the national Swedish neonatal screening program in 1986, and approximately 115,000 newborns are screened annually. Dried blood spot (DBS) screening with measurement of 17-hydroxyprogesterone (17OHP) is also offered to older childr...

Full description

Bibliographic Details
Main Authors: Rolf H. Zetterström, Leif Karlsson, Henrik Falhammar, Svetlana Lajic, Anna Nordenström
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:International Journal of Neonatal Screening
Subjects:
neonatal screening
congenital adrenal hyperplasia
CAH
21-hydroxylase deficiency
<i>CYP21A2</i>
dried blood spots
Online Access:https://www.mdpi.com/2409-515X/6/3/71

Similar Items

Similar Items